Contemporary, age-based trends in the incidence and management of patients with early-stage kidney cancer

作者：Tan Hung Jui^*; Filson Christopher P; Litwin Mark S

来源：Urologic Oncology-Seminars and Original Investigations, 2015, 33(1): 21.e19.

DOI：10.1016/j.urolonc.2014.10.002

• Kidney neoplasm
• Epidemiology
• Nephrectomy
• Aged

Purpose: Although kidney cancer incidence and nephrectomy rates have risen in tandem, clinical advances have generated new uncertainty regarding the optimal management of patients with small renal tumors, especially the elderly. To clarify existing practice patterns, we assessed contemporary trends in the incidence and management of patients with early-stage kidney cancer.
Materials and methods: Using Surveillance, Epidemiology, and End Results data, we identified adult patients diagnosed with T1aNOMO kidney cancer from 2000 to 2010. We determined age-adjusted and age-specific incidence and management rates (i.e., nonoperative, ablation, partial nephrectomy [PM, and radical nephrectomy) per 100,000 adults and determined the average annual percent change (AAPC). Finally. we compared management groups using multinomial logistic regression accounting for patient characteristics, cancer information, and county-level measures for health.
Results: From 2000 to 2010, we identified 41,645 adults diagnosed with T1aNOMO kidney cancer. Overall incidence increased from 3.7 to 7.0 per 100,000 adults (AAPC = 7.0%, P < 0.001). Over the study interval, rates of PN (AAPC = 13.1%, P < 0.0011 increased substantially, becoming the most used treatment by 2010. Among the elderly, rates of nonoperative management and ablation approached nephrectomy rates for those aged 75 to 84 years and became the predominant strategy for patients older than 84 years. Adjusting for clinical, oncological, and environmental factors, older patients less frequently underwent PN and more often received ablative or nonoperative management (P < 0.001).
Conclusions: As the incidence of early-stage kidney cancer rises, patients are increasingly treated with nonoperative and nephron-sparing strategies, especially among the most elderly. The broader array of treatment options suggests opportunities to better personalize kidney cancer care for seniors. Published by Elsevier Inc.

• 出版日期2015-1
• 单位UCLA